Paré, L <br/><br/>
Transcription factor-binding sites in the thymidylate synthase gene: predictors of outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin?  [electronic resource] 

 -  The pharmacogenomics journal  Oct 2008 
 - 315-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/sj.tpj.6500469  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Binding Sites<br/>Cohort Studies<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Promoter Regions, Genetic<br/>Regression Analysis<br/>Thymidylate Synthase--genetics<br/>Transcription Factors--metabolism<br/>Treatment Outcome